SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 98 filers reported holding SERES THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,341,000 | -54.1% | 696,785 | -4.2% | 0.03% | -21.6% |
| Q1 2022 | $5,105,000 | -22.3% | 727,258 | -7.4% | 0.04% | +5.7% |
| Q4 2021 | $6,567,000 | +7.9% | 785,519 | -10.2% | 0.04% | +34.6% |
| Q3 2021 | $6,089,000 | -94.9% | 874,923 | -83.4% | 0.03% | -94.4% |
| Q2 2021 | $118,856,000 | -3.8% | 5,280,154 | -12.0% | 0.46% | -23.1% |
| Q1 2021 | $123,527,000 | -13.4% | 5,999,356 | +3.0% | 0.60% | -25.3% |
| Q4 2020 | $142,678,000 | -6.2% | 5,823,603 | +5.3% | 0.81% | -40.0% |
| Q3 2020 | $152,176,000 | +337.5% | 5,531,670 | -25.3% | 1.35% | +195.8% |
| Q2 2020 | $34,781,000 | -42.1% | 7,400,245 | -56.0% | 0.46% | -19.1% |
| Q1 2020 | $60,106,000 | +110.6% | 16,836,640 | +103.5% | 0.56% | +25.6% |
| Q4 2019 | $28,543,000 | -7.1% | 8,273,223 | +8.0% | 0.45% | -17.8% |
| Q3 2019 | $30,724,000 | +97.0% | 7,661,963 | +58.2% | 0.55% | +78.4% |
| Q2 2019 | $15,595,000 | +177.3% | 4,843,074 | +491.7% | 0.31% | +106.8% |
| Q1 2019 | $5,623,000 | +37386.7% | 818,499 | +24968.9% | 0.15% | +14700.0% |
| Q4 2018 | $15,000 | -40.0% | 3,265 | -1.6% | 0.00% | 0.0% |
| Q3 2018 | $25,000 | – | 3,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |